A microfluidic biosensor architecture for the rapid detection of COVID-19

The lack of enough diagnostic capacity to detect severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) has been one of the major challenges in the control the 2019 COVID pandemic; this led to significant delay in prompt treatment of COVID-19 patients or accurately estimate disease situation....

Descripción completa

Detalles Bibliográficos
Autores principales: Muhsin, Sura A., He, Ying, Al-Amidie, Muthana, Sergovia, Karen, Abdullah, Amjed, Wang, Yang, Alkorjia, Omar, Hulsey, Robert A., Hunter, Gary L., Erdal, Zeynep K., Pletka, Ryan J., Hyleme, S. George, Wan, Xiu-Feng, Almasri, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251744/
https://www.ncbi.nlm.nih.gov/pubmed/37524456
http://dx.doi.org/10.1016/j.aca.2023.341378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251744/
https://www.ncbi.nlm.nih.gov/pubmed/37524456
http://dx.doi.org/10.1016/j.aca.2023.341378

Ejemplares similares